Can the Food and Drug Administration survive Trump? Are drug reviewers in the deep state? And what can Elon Musk teach us about the nature of reality?
We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we recap a chaotic week for the FDA, between an accusatory tweet from President Trump and a controversial press conference. Then, STAT Washington correspondent Lev Facher joins us to discuss how Trump’s crusade against the agency could do lasting damage to its reputation. Finally, STAT’s Erin Brodwin calls in to talk about what’s going on inside Neuralink, Elon Musk’s secretive neuroscience company on the verge of a mysterious announcement.
For more on what we cover, here’s the latest on the FDA; here’s the news on Neuralink; and here’s STAT’s complete coverage of the coronavirus pandemic.
We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].
